bosentan anhydrous has been researched along with Cholera Infantum in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Birnboeck, H; Eggers, H; Hopfgartner, G; Jonkman, JH; Meyer, J; Schmitt, R; van Marle, S; Viischer, HW; Weber, C | 1 |
1 trial(s) available for bosentan anhydrous and Cholera Infantum
Article | Year |
---|---|
Multiple-dose pharmacokinetics, safety, and tolerability of bosentan, an endothelin receptor antagonist, in healthy male volunteers.
Topics: Administration, Oral; Antihypertensive Agents; Area Under Curve; Blood Pressure; Bosentan; Diastole; Dose-Response Relationship, Drug; Double-Blind Method; Endothelin Receptor Antagonists; Gastrointestinal Diseases; Headache; Humans; Male; Metabolic Clearance Rate; Pyrimidines; Sulfonamides; Systole | 1999 |